Reduced severity of strokes in patients with silent brain infarctions

European Journal of Neurology

Volumn 18, Issue 7, 2011, Pages 962-971

  Kim, Y S ^a   Park, S S ^b   Lee, S H ^b   Yoon, B W ^b  

^a Hanyang University College of Medicine   (South Korea)

^b Seoul National University Hospital   (South Korea)

Author keywords

Ischaemic stroke; Ischaemic tolerance; Silent brain infarction; Stroke severity

Indexed keywords

ADULT; AGE; AGED; ARTICLE; BLEEDING; BRAIN INFARCTION; BRAIN ISCHEMIA; CLINICAL FEATURE; DISEASE SEVERITY; FEMALE; GENDER; HUMAN; INFORMATION PROCESSING; LEUKOARAIOSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MICROBLEED; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANKIN SCALE; RISK FACTOR; SILENT BRAIN INFARCTION;

AGE FACTORS; AGED; BRAIN INFARCTION; FEMALE; HUMANS; HYPERTENSION; IMAGE INTERPRETATION, COMPUTER-ASSISTED; LEUKOARAIOSIS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PREVALENCE; RECOVERY OF FUNCTION; RISK FACTORS; STROKE;

EID: 79958858637     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2010.03282.x     Document Type: Article

References (35)

1. Wilterdink JL, Bendixen B, Adams HP Jr, Woolson RF, Clarke WR, Hansen MD. Effect of prior aspirin use on stroke severity in the trial of Org 10172 in acute stroke treatment (TOAST). Stroke 2001; 32: 2836-2840.
2. Kalra L, Perez I, Smithard DG, Sulch D. Does prior use of aspirin affect outcome in ischemic stroke? Am J Med 2000; 108: 205-209.
3. Karepov V, Bornstein NM, Hass Y, Korczyn AD. Does daily aspirin diminish severity of first-ever stroke? Arch Neurol 1997; 54: 1369-1371.
4. Ricci S, Lewis S, Sandercock P. Previous use of aspirin and baseline stroke severity: an analysis of 17, 850 patients in the International Stroke Trial. Stroke 2006; 37: 1737-1740.
5. Deplanque D, Masse I, Lefebvre C, Libersa C, Leys D, Bordet R. Prior TIA, lipid-lowering drug use, and physical activity decrease ischemic stroke severity. Neurology 2006; 67: 1403-1410.
6. Krarup LH, Truelsen T, Gluud C, et al. Prestroke physical activity is associated with severity and long-term outcome from first-ever stroke. Neurology 2008; 71: 1313-1318.
7. Selim M, Savitz S, Linfante I, Caplan L, Schlaug G. Effect of pre-stroke use of ACE inhibitors on ischemic stroke severity. BMC Neurol 2005; 5: 10.
8. Olsen TS, Christensen RH, Kammersgaard LP, Andersen KK. Higher total serum cholesterol levels are associated with less severe strokes and lower all-cause mortality: ten-year follow-up of ischemic strokes in the Copenhagen Stroke Study. Stroke 2007; 38: 2646-2651.
9. Moncayo J, de Freitas GR, Bogousslavsky J, Altieri M, van Melle G. Do transient ischemic attacks have a neuroprotective effect? Neurology 2000; 54: 2089-2094.
10. Sitzer M, Foerch C, Neumann-Haefelin T, et al. Transient ischaemic attack preceding anterior circulation infarction is independently associated with favourable outcome. J Neurol Neurosurg Psychiatry 2004; 75: 659-660.
11. Fu Y, Sun JL, Ma JF, et al. The neuroprotection of prodromal transient ischaemic attack on cerebral infarction. Eur J Neurol 2008; 15: 797-801.
12. Wegener S, Gottschalk B, Jovanovic V, et al. Transient ischemic attacks before ischemic stroke: preconditioning the human brain? A multicenter magnetic resonance imaging study. Stroke 2004; 35: 616-621.
13. Weih M, Kallenberg K, Bergk A, et al. Attenuated stroke severity after prodromal TIA: a role for ischemic tolerance in the brain? Stroke 1999; 30: 1851-1854.
14. Vermeer SE, Longstreth WT Jr, Koudstaal PJ. Silent brain infarcts: a systematic review. Lancet Neurol 2007; 6: 611-619.
15. Pantoni L. Pathophysiology of age-related cerebral white matter changes. Cerebrovasc Dis 2002; 13(Suppl 2): 7-10.
16. Roob G, Schmidt R, Kapeller P, Lechner A, Hartung HP, Fazekas F. MRI evidence of past cerebral microbleeds in a healthy elderly population. Neurology 1999; 52: 991-994.
17. de Leeuw FE, de Groot JC, Oudkerk M, et al. Hypertension and cerebral white matter lesions in a prospective cohort study. Brain 2002; 125: 765-772.
18. Vermeer SE, Koudstaal PJ, Oudkerk M, Hofman A, Breteler MM. Prevalence and risk factors of silent brain infarcts in the population-based Rotterdam Scan Study. Stroke 2002; 33: 21-25.
19. Kuller LH, Longstreth WT Jr, Arnold AM, Bernick C, Bryan RN, Beauchamp NJ Jr. White matter hyperintensity on cranial magnetic resonance imaging: a predictor of stroke. Stroke 2004; 35: 1821-1825.
20. Vermeer SE, Prins ND, den Heijer T, Hofman A, Koudstaal PJ, Breteler MM. Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med 2003; 348: 1215-1222.
21. van Gijn J. Leukoaraiosis and vascular dementia. Neurology 1998; 51: S3-S8.
22. Steffens DC, Helms MJ, Krishnan KR, Burke GL. Cerebrovascular disease and depression symptoms in the cardiovascular health study. Stroke 1999; 30: 2159-2166.
23. Fazekas F, Niederkorn K, Schmidt R, et al. White matter signal abnormalities in normal individuals: correlation with carotid ultrasonography, cerebral blood flow measurements, and cerebrovascular risk factors. Stroke 1988; 19: 1285-1288.
24. Lee SH, Kwon SJ, Kim KS, Yoon BW, Roh JK. Cerebral microbleeds in patients with hypertensive stroke. Topographical distribution in the supratentorial area. J Neurol 2004; 251: 1183-1189.
25. Sacco RL, DeRosa JT, Haley EC Jr, et al. Glycine antagonist in neuroprotection for patients with acute stroke: GAIN Americas: a randomized controlled trial. JAMA 2001; 285: 1719-1728.
26. Sulter G, Steen C, De Keyser J. Use of the Barthel index and modified Rankin scale in acute stroke trials. Stroke 1999; 30: 1538-1541.
27. Kato H, Izumiyama M, Izumiyama K, Takahashi A, Itoyama Y. Silent cerebral microbleeds on T2*-weighted MRI: correlation with stroke subtype, stroke recurrence, and leukoaraiosis. Stroke 2002; 33: 1536-1540.
28. Johnston SC. Ischemic preconditioning from transient ischemic attacks? Data from the Northern California TIA Study Stroke 2004; 35: 2680-2682.
29. Hausenloy DJ, Mwamure PK, Venugopal V, et al. Effect of remote ischaemic preconditioning on myocardial injury in patients undergoing coronary artery bypass graft surgery: a randomised controlled trial. Lancet 2007; 370: 575-579.
30. Boon A, Lodder J, Heuts-van Raak L, Kessels F. Silent brain infarcts in 755 consecutive patients with a first-ever supratentorial ischemic stroke. Relationship with index-stroke subtype, vascular risk factors, and mortality. Stroke 1994; 25: 2384-2390.
31. Adachi T, Kobayashi S, Yamaguchi S. Frequency and pathogenesis of silent subcortical brain infarction in acute first-ever ischemic stroke. Intern Med 2002; 41: 103-108.
32. Pantoni L, Garcia JH. The significance of cerebral white matter abnormalities 100years after Binswanger's report. A review. Stroke 1995; 26: 1293-1301.
33. Fazekas F, Kleinert R, Roob G, et al. Histopathologic analysis of foci of signal loss on gradient-echo T2*-weighted MR images in patients with spontaneous intracerebral hemorrhage: evidence of microangiopathy-related microbleeds. AJNR Am J Neuroradiol 1999; 20: 637-642.
34. Briley DP, Haroon S, Sergent SM, Thomas S. Does leukoaraiosis predict morbidity and mortality? Neurology 2000; 54: 90-94.
35. Lee SH, Kim BJ, Ryu WS, et al. White matter lesions and poor outcome after intracerebral hemorrhage: a nationwide cohort study. Neurology 2010; 74: 1502-1510.